Reinventing the Sequencer

Helicos' Bill Efcavitch is confident that he can produce a machine that can sequence a genome for $1,000 in ten days. It hasn't been an easy road.

Written byKerry Grens
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

While giving a tour of Helicos BioSciences' laboratories in Cambridge, Mass., Bill Efcavitch pauses and pats a refrigerator-size 3700 DNA sequencer. The sequencer was made by Applied Biosystems, where Efcavitch worked until 2004. "It's the platform that sequenced the human genome," says Efcavitch, Helicos' senior vice president of product research and development, "and I managed the group that did that." Now, the instrument he helped develop (which Helicos purchased in the used market) serves as an analytical tool to back up a new style of genome sequencer that Efcavitch is developing. Helicos promises to deliver what the many model 3700 instruments did for millions of dollars in several years for just $1,000 in 10 days.

Like Efcavitch's projects before it, Helicos' HeliScope sequencer is an exercise in ambition. A prototype, also a refrigerator-size box, stands in Helicos' engineering department. Efcavitch pulls open a door on the box, revealing a touch-screen ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform